FibroGen, Inc. (FGEN)
NASDAQ: FGEN · Real-Time Price · USD
10.63
-0.55 (-4.92%)
At close: Aug 25, 2025, 4:00 PM
10.57
-0.06 (-0.56%)
After-hours: Aug 25, 2025, 5:25 PM EDT

FibroGen Stock Forecast

Stock Price Forecast

The 2 analysts that cover FibroGen stock have a consensus rating of "Strong Buy" and an average price target of $146.5, which forecasts a 1,278.17% increase in the stock price over the next year. The lowest target is $43 and the highest is $250.

Price Target: $146.5 (+1,278.17%)
Analyst Consensus: Strong Buy
TargetLowAverageMedianHigh
Price$43$146.5$250$250
Change+304.52%+1278.2%+2251.8%+2251.8%

Analyst Ratings

The average analyst rating for FibroGen stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

RatingMar '25Apr '25May '25Jun '25Jul '25Aug '25
Strong Buy111112
Buy000000
Hold000000
Sell000000
Strong Sell000000
Total111112

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Maintains
$10$43
Strong BuyMaintains$10$43+304.52%Aug 7, 2025
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$250
Strong BuyReiterates$250+2,251.83%May 13, 2025
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$250
Strong BuyReiterates$250+2,251.83%Mar 18, 2025
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$250
Strong BuyReiterates$250+2,251.83%Feb 20, 2025
B of A Securities
B of A Securities
Sell
Downgrades
$100$50
SellDowngrades$100$50+370.37%Aug 8, 2023
More Analyst Ratings

Financial Forecast

Revenue This Year
12.95M
from 29.62M
Decreased by -56.27%
Revenue Next Year
6.48M
from 12.95M
Decreased by -50.00%
EPS This Year
2.74
from -11.89
EPS Next Year
-9.61
from 2.74
Fiscal YearFY 2020FY 2021FY 2022FY 2023FY 2024FY 2025FY 2026FY 2027
Period EndingDec 31, 2020Dec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026Dec 31, 2027
Revenue
176.32M235.31M140.73M46.80M29.62M12.95M6.48M6.48M
Revenue Growth
-31.28%33.46%-40.19%-66.74%-36.71%-56.27%-50.00%-
EPS
-52.67-78.51-78.45-73.03-11.892.74-9.61-16.39
EPS Growth
--------
Forward PE
-----3.87--
No. Analysts
-----444
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue2025202620272028
High13.3M7.0M7.0M
Avg13.0M6.5M6.5M
Low12.4M5.9M5.9M

Revenue Growth

Revenue Growth2025202620272028
High
-55.0%
-45.7%
8.6%
Avg
-56.3%
-50.0%
-
Low
-58.0%
-54.6%
-9.2%

EPS Forecast

EPS2025202620272028
High2.823.27-14.44
Avg2.74-9.61-16.39
Low2.64-21.52-18.01

EPS Growth

EPS Growth2025202620272028
High-
19.0%
-
Avg---
Low---
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.